Key result
Genetic variants in the GABRA3 gene (allele A of rs750841 and allele G of rs12688128) were significantly associated with thyrotoxic hypokalaemic periodic paralysis (RR 19; 95% CI 2.4-151.6; P<0.0002).
Why the study?
Are genetic variants in the GABRA3 gene associated with thyrotoxic hypokalaemic periodic paralysis in a Thai population?
Case-Control (n=100)
Are genetic variants in the GABRA3 gene associated with thyrotoxic hypokalaemic periodic paralysis in a Thai population?
Relative Risk: 19 (95% CI 2.4–151.6)
Absolute Event Rate: 28% vs 2%
p-value: p=<0.0002
SNPs at intron 3 of the GABRA3 gene are strongly associated with susceptibility to thyrotoxic hypokalaemic periodic paralysis in the Thai population.
GABRA3 variants may flag susceptibility in Thai thyrotoxic patients; leaves open prospective validation before any clinical application.
BACKGROUND: Genetic predisposition has been suggested to play role in the pathogenesis of thyrotoxic hypokalaemic periodic paralysis (THPP). OBJECTIVES: In this study, we assessed the differences of single-nucleotide polymorphisms (SNP) allelic frequency between THPP patients and well-characterized controls in order to find the susceptibility genetic variants related to THPP using microarray-based assessments on pooled DNA. METHODS: Fifty cases of THPP and 50 male hyperthyroid patients without hypokalaemia as controls were recruited. Equal amounts of individual genomic DNA were pooled from each group. Estimated allele frequencies of SNPs were derived by averaging relative allele signal score obtained by Affymetrix GeneChip(R) Mapping 10K Arrays. RESULTS: Sixty-nine loci that display robust allele frequency differences between THPP and controls were identified. SNP rs750841 (A > T) in intron 3 of the gamma-aminobutyric acid (GABA) receptor alpha3 subunit (GABRA3) gene possessed the most significant difference in allele frequency (27% in THPP case and 5% in controls, P = 0.007). Actual allele frequencies obtained from genotyping in each individual were very similar to the estimated frequency from the pools (28% in THPP and 2% in controls, and P = 0.0002). Nearby DNA sequences of GABRA3 were sequenced and an additional two SNPs were found (A > C at exon 1 and G > T of rs12688128). Allele A of rs750841 and allele G of rs12688128 in intron 3 were predominantly found in THPP with significant genetic relative risk of 19 (P < 0.0002; 95%CI 2.4-151.6). CONCLUSIONS: Whole-genome scanning on pooled DNA provides an accurate, useful screening tool for elucidating genetic underpinnings of THPP. SNPs at intron 3 of GABRA3 are found to be associated with THPP.
No takes yet. Share an insight, caveat, or question.
Jongjaroenprasert et al. (2007) conducted a case-control in Thyrotoxic hypokalaemic periodic paralysis (THPP) (n=100). Genetic variants in GABRA3 gene (rs750841 and rs12688128) vs. Hyperthyroid patients without hypokalaemia was evaluated on Allele frequency of SNP rs750841 (A > T) in GABRA3 gene (RR 19, 95% CI 2.4-151.6, p=<0.0002). Genetic variants in the GABRA3 gene (allele A of rs750841 and allele G of rs12688128) were significantly associated with thyrotoxic hypokalaemic periodic paralysis (RR 19; 95% CI 2.4-151.6; P<0.0002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: